Viveve Medical (VIVE) Tops Q3 EPS by 7c

Viveve Medical (NASDAQ: VIVE) reported Q3 EPS of ($0.59), $0.07 better than the analyst estimate of ($0.66). Revenue for the quarter came in at $17 million versus the consensus estimate of $1.68 million.

For earnings history and earnings-related data on Viveve Medical (VIVE) click here.

You May Also Be Interested In

• MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
• Goldman: 'Our key conclusion is that AI is likely to be credit-positive for banks', 'Rearming Our Overweight Stance on Banks'
• UBS Reiterates Neutral Rating on Pilgrim's Pride (PPC) on 'Challenging' Near-Term Fundamentals